GENEDX HOLDINGS (WGS) Upgraded to Strong Buy: Here's What You Should Know

Core Viewpoint - GeneDx Holdings Corp. has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Revisions - The Zacks Consensus Estimate for GeneDx Holdings for the fiscal year ending December 2025 is projected at $0.97 per share, reflecting a substantial increase of 288% from the previous year's reported figure [9]. - Over the past three months, the Zacks Consensus Estimate for GeneDx Holdings has risen by 86.5%, indicating a strong upward trend in earnings estimates [9]. Zacks Rating System - The Zacks rating system is based solely on a company's changing earnings picture, making it a reliable tool for investors to gauge stock performance [2][3]. - The Zacks Rank system categorizes stocks into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, positioning GeneDx Holdings among the best in terms of earnings estimate revisions [10][11].